IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 4471 
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

RESEARCH ARTICLE

Comparison of nebivolol and atenolol on blood pressure, blood sugar, and lipid profile in patients of essential hypertension

Badar V A, Hiware Sachin K, Shrivastava Meena P, Thawani V R, Hardas M M

Year : 2011| Volume: 43| Issue : 4 | Page no: 437-440

   This article has been cited by
 
1 Therapeutic Properties of Highly Selective -blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease
Waleed AlHabeeb, Sanaa Mrabeti, Ahmed Adel Ibrahim Abdelsalam
Cardiovascular Drugs and Therapy. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 The role of nebivolol in the management of hypertensive patients: from pharmacological profile to treatment guidelines
Claudio Ferri
Future Cardiology. 2021; 17(8): 1421
[Pubmed]  [Google Scholar] [DOI]
3 A pilot study to identify the longitudinal serum metabolite profiles to predict the development of hyperuricemia in essential hypertension
Heru Zhao, Yin Zhang, Bin Liu, Lulu Zhang, Mei Bao, Li Li, Ning Zhao, Muhummad Hussain, Yuexi Wang, Jianfeng Yi, Peng Chen, Cheng Lu
Clinica Chimica Acta. 2020; 510: 466
[Pubmed]  [Google Scholar] [DOI]
4 Real-world efficacy and safety of nebivolol in Korean patients with hypertension from the BENEFIT KOREA study
Jinho Shin, Yu Jeong Choi, Geu-Ru Hong, Dong Woon Jeon, Dae-Hyeok Kim, Young Youp Koh, Giuseppe Mancia, Athanasios J. Manolis, Hyuck-Jun Yoon, Sang Won Park
Journal of Hypertension. 2020; 38(3): 527
[Pubmed]  [Google Scholar] [DOI]
5 Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association
Suzanne V. Arnold, Deepak L. Bhatt, Gregory W. Barsness, Alexis L. Beatty, Prakash C. Deedwania, Silvio E. Inzucchi, Mikhail Kosiborod, Lawrence A. Leiter, Kasia J. Lipska, Jonathan D. Newman, Francine K. Welty
Circulation. 2020; 141(19)
[Pubmed]  [Google Scholar] [DOI]
6 Type of Beta-blocker Use Among Patients with Versus without Diabetes after Myocardial Infarction
Suzanne V. Arnold,John A. Spertus,Kasia J. Lipska,David E. Lanfear,Fengming Tang,Anna Grodzinsky,MHSc Darren K. McGuire MD,M. Odette Gore,Abhinav Goyal,Thomas M. Maddox,Mikhail Kosiborod
American Heart Journal. 2014;
[Pubmed]  [Google Scholar] [DOI]
7 Hypertension treatment: Is there a place for b-adrenoblockers?
L O Minushkina
Systemic Hypertension. 2013; 10(1): 48
[Pubmed]  [Google Scholar] [DOI]

 

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow